242 related articles for article (PubMed ID: 17548194)
1. Synthesis of marine alkaloid: 8,9-dihydrocoscinamide B and its analogues as Novel class of antileishmanial agents.
Gupta L; Talwar A; Nishi ; Palne S; Gupta S; Chauhan PM
Bioorg Med Chem Lett; 2007 Jul; 17(14):4075-9. PubMed ID: 17548194
[TBL] [Abstract][Full Text] [Related]
2. Dihydropyrido[2,3-d]pyrimidines as a new class of antileishmanial agents.
Agarwal A; Ramesh ; Ashutosh ; Goyal N; Chauhan PM; Gupta S
Bioorg Med Chem; 2005 Dec; 13(24):6678-84. PubMed ID: 16126395
[TBL] [Abstract][Full Text] [Related]
3. Antileishmanial activity of an indole alkaloid from Peschiera australis.
Delorenzi JC; Attias M; Gattass CR; Andrade M; Rezende C; da Cunha Pinto A; Henriques AT; Bou-Habib DC; Saraiva EM
Antimicrob Agents Chemother; 2001 May; 45(5):1349-54. PubMed ID: 11302794
[TBL] [Abstract][Full Text] [Related]
4. Antileishmanial activity of indole alkaloids from Aspidosperma ramiflorum.
Tanaka JC; da Silva CC; Ferreira IC; Machado GM; Leon LL; de Oliveira AJ
Phytomedicine; 2007 Jun; 14(6):377-80. PubMed ID: 17140782
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of chromenochalcones and evaluation of their in vitro antileishmanial activity.
Narender T; Khaliq T; Shweta ; Nishi ; Goyal N; Gupta S
Bioorg Med Chem; 2005 Dec; 13(23):6543-50. PubMed ID: 16185885
[TBL] [Abstract][Full Text] [Related]
6. Preparation and antileishmanial activity of lipophilic N-alkyl diamines.
da Costa CF; Coimbra ES; Braga FG; dos Reis RC; da Silva AD; de Almeida MV
Biomed Pharmacother; 2009 Jan; 63(1):40-2. PubMed ID: 18262385
[TBL] [Abstract][Full Text] [Related]
7. Arylanthranilodinitriles: a new biaryl class of antileishmanial agents.
Singh FV; Vatsyayan R; Roy U; Goel A
Bioorg Med Chem Lett; 2006 May; 16(10):2734-7. PubMed ID: 16503140
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of trifluralin analogues as antileishmanial agents.
Esteves MA; Fragiadaki I; Lopes R; Scoulica E; Cruz ME
Bioorg Med Chem; 2010 Jan; 18(1):274-81. PubMed ID: 19926293
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines.
Sunduru N; Nishi ; Palne S; Chauhan PM; Gupta S
Eur J Med Chem; 2009 Jun; 44(6):2473-81. PubMed ID: 19217698
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antileishmanial profile of some novel terpenyl pyrimidines.
Pandey S; Suryawanshi SN; Gupta S; Srivastava VM
Eur J Med Chem; 2004 Nov; 39(11):969-73. PubMed ID: 15501546
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of chalcone analogues with increased antileishmanial activity.
Boeck P; Bandeira Falcão CA; Leal PC; Yunes RA; Filho VC; Torres-Santos EC; Rossi-Bergmann B
Bioorg Med Chem; 2006 Mar; 14(5):1538-45. PubMed ID: 16386424
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of leishmaniasis part II: synthesis and bioevaluation of substituted arylketene dithioacetals as antileishmanial agents.
Pandey S; Suryawanshi SN; Gupta S; Srivastava VM
Eur J Med Chem; 2005 Aug; 40(8):751-6. PubMed ID: 15907348
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antileishmanial activity of piperoyl-amino acid conjugates.
Singh IP; Jain SK; Kaur A; Singh S; Kumar R; Garg P; Sharma SS; Arora SK
Eur J Med Chem; 2010 Aug; 45(8):3439-45. PubMed ID: 20546981
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents.
Guillon J; Forfar I; Mamani-Matsuda M; Desplat V; Saliège M; Thiolat D; Massip S; Tabourier A; Léger JM; Dufaure B; Haumont G; Jarry C; Mossalayi D
Bioorg Med Chem; 2007 Jan; 15(1):194-210. PubMed ID: 17049253
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of leishmaniasis part-VIII: synthesis and bioevaluation of novel chalcones.
Suryawanshi SN; Chandra N; Kumar P; Porwal J; Gupta S
Eur J Med Chem; 2008 Nov; 43(11):2473-8. PubMed ID: 18243420
[TBL] [Abstract][Full Text] [Related]
16. Antileishmanial activity of Eugenol-rich essential oil from Ocimum gratissimum.
Ueda-Nakamura T; Mendonça-Filho RR; Morgado-Díaz JA; Korehisa Maza P; Prado Dias Filho B; Aparício Garcia Cortez D; Alviano DS; Rosa Mdo S; Lopes AH; Alviano CS; Nakamura CV
Parasitol Int; 2006 Jun; 55(2):99-105. PubMed ID: 16343984
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of novel 5-(5-amino-1-aryl-1H-pyrazol-4-yl)-1H-tetrazole derivatives against promastigotes and amastigotes of Leishmania amazonensis.
dos Santos Faiões V; Leon LL; Canto-Cavalheiro MM; Torres-Santos EC; Bernardino AM; Vegi PF; dos Santos MS
Chem Biol Drug Des; 2014 Mar; 83(3):272-7. PubMed ID: 24119090
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of new [1,2,4]triazino[5,6-b]indol-3-ylthio-1,3,5-triazines and [1,2,4]triazino[5,6-b]indol-3-ylthio-pyrimidines against Leishmania donovani.
Gupta L; Sunduru N; Verma A; Srivastava S; Gupta S; Goyal N; Chauhan PM
Eur J Med Chem; 2010 Jun; 45(6):2359-65. PubMed ID: 20371140
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of indolyl glyoxylamides as a new class of antileishmanial agents.
Chauhan SS; Gupta L; Mittal M; Vishwakarma P; Gupta S; Chauhan PM
Bioorg Med Chem Lett; 2010 Nov; 20(21):6191-4. PubMed ID: 20850302
[TBL] [Abstract][Full Text] [Related]
20. Effect of 3-alkylpyridine marine alkaloid analogues in Leishmania species related to American cutaneous leishmaniasis.
Machado PA; Hilário FF; Carvalho LO; Silveira ML; Alves RB; Freitas RP; Coimbra ES
Chem Biol Drug Des; 2012 Nov; 80(5):745-51. PubMed ID: 22882996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
